Back
HLS Therapeutics, Inc. Stock Predictions
Stock Forecasting AI Could Help Triple Your Money This Year
Try it now for free.
Sell
28
HLS.TO
HLS Therapeutics, Inc.
Last Price:
$4.70
Seasonality Move:
1.44%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.HLS Therapeutics, Inc. Stock Forecast
-
Is HLS Therapeutics, Inc. Stock Undervalued?The current HLS Therapeutics, Inc. [HLS.TO] share price is $4.79. The Score for HLS.TO is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
HLS.TO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will HLS Therapeutics, Inc. Stock Go Up Next Year?
Data Unavailable
HLS Therapeutics, Inc. Stock Rating
Data Unavailable
HLS Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
TSX
Country:
Canada
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
hlstherapeutics.com
52-Week Data
52-Week High:
5.77
52-Week Low:
3.70
Prediction Charts
Market Cap:
149.8M
Price in USD:
4.79
Volume:
200
Beta:
0.76
Technical Analysis
SMA50:
5.16
SMA100:
5.28
SMA200:
4.96
52-Wk Change:
23.77%
Stock Predictions
-
Is HLS Therapeutics, Inc. stock public?Yes, HLS Therapeutics, Inc. is a publicly traded company.
-
What is the HLS Therapeutics, Inc. stock quote today?The HLS Therapeutics, Inc. stock price is 4.79 USD today.
-
How to buy HLS Therapeutics, Inc. stock online?You can buy HLS Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-4 | 4.89 | 4.91 | 4.92 | 4.86 |
| Dec-5 | 4.89 | 4.86 | 4.91 | 4.85 |
| Dec-8 | 4.91 | 4.85 | 4.91 | 4.83 |
| Dec-9 | 4.84 | 5.00 | 5.00 | 4.81 |
| Dec-10 | 5.00 | 4.99 | 5.00 | 4.87 |
| Dec-11 | 4.97 | 4.95 | 4.99 | 4.88 |
| Dec-12 | 4.95 | 4.99 | 4.99 | 4.88 |
| Dec-15 | 4.90 | 4.90 | 4.98 | 4.86 |
| Dec-16 | 4.89 | 4.87 | 4.89 | 4.83 |
| Dec-17 | 4.89 | 4.91 | 4.96 | 4.87 |
| Dec-18 | 4.98 | 4.90 | 4.98 | 4.89 |
| Dec-19 | 4.99 | 4.81 | 4.99 | 4.78 |
| Dec-22 | 4.81 | 4.75 | 4.83 | 4.70 |
| Dec-24 | 4.75 | 4.79 | 4.79 | 4.75 |
HLS Therapeutics, Inc. Earnings
Data Unavailable
HLS Therapeutics, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.26 per share, and an increase next year of $0.28 per share.
* HLS Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.